关注
Swapnali Londhe
Swapnali Londhe
CSIR-Indian Institute of Chemical Technology
在 csiriict.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Silver and gold nanoparticles: Potential cancer theranostic applications, recent development, challenges, and future perspectives
S Londhe, S Haque, CR Patra
Gold and Silver Nanoparticles, 247-290, 2023
122023
Gold and Silver Nanoparticles
S Londhe, S Haque, CR Patra
Elsevier, 2023
92023
Silver nitroprusside nanoparticles for breast cancer therapy: in vitro and in vivo approach
S Londhe, S Haque, S Tripathy, S Bojja, CR Patra
Nanoscale 15 (23), 10017-10032, 2023
72023
ROS mediated Cu [Fe (CN) 5NO] nanoparticles for triple negative breast cancer: A detailed study in preclinical mouse model
S Tripathy, S Haque, S Londhe, S Das, CC Norbert, Y Chandra, ...
Biomaterials Advances 160, 213832, 2024
42024
Biomedical applications of europium hydroxide nanorods
S Londhe, CR Patra
Nanomedicine 17 (1), 5-8, 2022
32022
Nitroprusside and metal nitroprusside nano analogues for cancer therapy
S Tripathy, S Londhe, CR Patra
Biomedical Materials 19 (3), 032001, 2024
22024
Copper nitroprusside analogue nanoparticles against melanoma: detailed in vitro and in vivo investigation
S Tripathy, S Londhe, A Patel, S Saha, Y Chandra, CR Patra
Nanoscale 16 (28), 13580-13596, 2024
12024
Toxicological evaluation of therapeutically active zinc oxide nanoflowers in pre-clinical mouse model
AK Barui, VS Bollu, S Londhe, SS Deshpande, S Das, SK Nethi, ...
NanoImpact 31, 100479, 2023
12023
Therapeutic Potential of Silver Nitroprusside Nanoparticles for Melanoma
S Londhe, S Tripathy, S Saha, A Patel, Y Chandra, CR Patra
ACS Applied Bio Materials, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–9